Midway through trading Tuesday, the Dow traded down 0.47 percent to 16,453.62 while the NASDAQ tumbled 0.53 percent to 4,116.16. The S&P also fell, dropping 0.37 percent to 1,877.72.
Leading and Lagging Sectors
Tuesday morning, the energy sector proved to be a source of strength for the market. Leading the sector was strength from Forest Oil (NYSE: FST) and Swift Energy Co (NYSE: SFY). Financial shares declined around 0.57 percent in Tuesday's trading.
Top 10 High Tech Stocks To Watch Right Now: Point.360(PTSX)
Point.360 operates as an integrated media management services company in the United States. It offers film, video and audio post-production, archival, duplication, computer graphics, and data distribution services. The company also provides services to edit, master, reformat, covert, archive, and distribute its clients? film and video content, including television programming, feature films, and movie trailers. Its value-added services comprise visual effects, video and data editing, graphics and animation, digital color correction, picture restoration, audio post-production, audio restoration and layback, closed captioning and subtitling, foreign language mastering, standards conversion, broadcast encoding, global distribution and syndication, and archival services. In addition, Point.360 is involved in the rental and sale of DVDs and video games to consumers through its Movie>Q retail stores. Its customers include independent motion picture and television production com panies, television program suppliers, national television networks, infomercial providers, local television stations, television program syndicators, corporations, and educational institutions, as well as advertising agencies, and corporate or instructional video providers. The company is based in Burbank, California.
Advisors' Opinion:- [By Lisa Levin]
Point.360 (NASDAQ: PTSX) shares reached a new 52-week low of $0.528. Point.360's trailing-twelve-month ROE is -12.69%.
QC Holdings (NASDAQ: QCCO) shares tumbled 3.68% to reach a new 52-week low of $1.83. QC Holdings shares have dropped 42.60% over the past 52 weeks, while the S&P 500 index has gained 31.67% in the same period.
Hot Healthcare Technology Companies To Buy Right Now: FedEx Corporation(FDX)
FedEx Corporation provides transportation, e-commerce, and business services in the United States and internationally. It operates in four segments: FedEx Express, FedEx Ground, FedEx Freight, and FedEx Services. The FedEx Express segment offers various shipping services for the delivery of packages and freight. This segment also provides international trade services specializing in customs brokerage, and ocean and air freight forwarding services; customs clearance services, as well as global trade data, an information tool that allows customers to track and manage imports; and international trade advisory services, including assistance with the customs-trade partnership against terrorism program, as well as publishes customs duty and tax information in various customs areas. In addition, it offers supply chain solutions, including critical inventory logistics, transportation management, fulfillment, and fleet services. The FedEx Ground segment provides business and reside ntial ground package delivery services. It primarily serves customers in the small-package market in North America. The FedEx Freight segment offers less-than-truckload freight services, as well as freight-shipping services. As of May 31, 2010, this segment operated approximately 60,000 vehicles and trailers from a network of 492 service centers. The FedEx Services segment provides sales, marketing, information technology support, and customer service support services; and access to copying and digital printing through retail and Web-based platforms, signs and graphics, professional finishing, computer rentals, and a range of ground shipping and time-definite express shipping services. The company was founded in 1971 and is headquartered in Memphis, Tennessee.
Advisors' Opinion:- [By Demitrios Kalogeropoulos]
Very patient shippers
UPS is dealing with a major shift in demand for overseas shipping. Customers are fleeing from super-quick international delivery services, making that business a much less-profitable one. FedEx (NYSE: FDX ) , for example, has seen shippers increasingly choose its "economy" international service, which arrives in two to five days, over its "priority" option that's delivered in one to three days. That shift has taken a whack at earnings. FedEx's express segment profits were down 66% last quarter, dragging operating income lower by 28% companywide. - [By Laura Brodbeck]
Next week, investors will be waiting for several key earnings reports including Oracle Corporation (NASDAQ: ORCL), Nike, Inc. (NYSE: NKE), BlackBerry (NASDAQ: BBRY), Rite Aid Corporation (NYSE: RAD), and FedEx Corporation (NYSE: FDX).
- [By WWW.DAILYFINANCE.COM]
Alamy SAN FRANCISCO -- Apple (AAPL) has cut in half the time it takes to give refunds to online store customers who want to return their iPhones and other gadgets, a small but crucial step to try to get more people to buy direct from its website. The move is a big upfront expense on Apple's part, but could pay off in the long run if the company can lure online customers away from retailers such as Amazon.com (AMZN) and Best Buy (BBY), industry experts say. According to retail-intelligence firm StellaService, customers who buy a product from Apple's online store can get a refund in under a week, versus 10 days previously. Apple is processing refunds at a faster rate because the company now uses an expedited service, FedEx 2Day, to let customers ship returned items with prepaid labels to its warehouse in three days. StellaService researchers first noted the improvement in refund processing times in November, but chalked it up to a temporary measure for the busy holiday season. The company, which orders items from Apple's website several times a day for research purposes, also discovered that packages were stamped with FedEx 2Day, rather than a Newgistics prepaid label. A source with knowledge of the new procedure confirmed that customers will incur no additional cost. "This is the first time we're seeing an investment like this on the returns side," Kevon Hills, StellaService's vice president of research, told Reuters. StellaService does business with Amazon-owned Zappos, but declined to disclose whether its customer base included Apple, Amazon or eBay (EBAY). Amazon remains the frontrunner in online retail, but the race is heating up. Trade publication Internet Retailer estimated that Apple recently took the No. 2 spot from Staples (SPLS) in worldwide sales. These rankings don't include sales by third parties. Apple experienced a 24 percent increase in online sales to $18.3 billion in 2013, Internet Retailer estimated. E-commerce experts say Apple
- [By Melvin Backman]
Earnings: Four big names are reporting next week: Shipping giant FedEx (FDX), gun maker Smith & Wesson (SWHC), tech giant Oracle (ORCL, Tech30) and BlackBerry (BBRY, Tech30).
Hot Healthcare Technology Companies To Buy Right Now: AVEO Pharmaceuticals Inc.(AVEO)
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of cancer therapeutics. The company?s lead product candidate, Tivozanib (AV-951), is a novel, highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2, and 3. It is also leading the clinical development of AV-299, which includes conducting multiple Phase I clinical trials and preparing for the conduct of multiple Phase II clinical trials. The company?s product candidate in preclinical development is AV-203, a potent ErbB3 antibody that has demonstrated efficacy in vivo. It has strategic partnerships with OSI Pharmaceuticals, Inc., Merck, and Biogen Idec, Inc. AVEO Pharmaceuticals was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. The company was founded in 2001 and is based in Cambridge, Massachusetts.
Advisors' Opinion:- [By Sean Williams]
What: Shares of AVEO Pharmaceuticals (NASDAQ: AVEO ) , a cancer therapeutics company, collapsed as much as 27% following the release of briefing documents today in anticipation of AVEO's meeting with the Food and Drug Administration panel on Thursday.
- [By Laura Brodbeck]
Thursday
Earnings Expected From: AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), Kirkland��, Inc (NASDAQ: KIRK), Dollar General Corporation (NYSE: DG), Stein Mart, Inc. (SMRT: NASDAQ), Mattress Firm Holding Corp. (NASDAQ: MRFM), SeaWorld Entertainment (NYSE: SEAS), Vaalco Energy Inc (NYSE: EGY) Economic Releases Expected: Chinese retail sales, French CPI, Brazilian retail sales, US retail sales, Japanese industrial productionFriday
- [By Eric Volkman]
AVEO Oncology (NASDAQ: AVEO ) will have to plow forward with far less manpower. It announced it will reduce its headcount by around 140 people, or roughly 62% of its current workforce, across the company. The cuts are part of a strategic restructuring initiative aimed at improving the firm's viability in the immediate future.�
- [By Chris Rees]
We have previously published two articles about Aveo Pharmaceuticals (AVEO) and its kidney cancer drug Tivozanib. This article will make more sense if you read those articles first. You can find the first one here and the second one here. We have been working on the Aveo story for over a year, and were convinced the FDA would interpret the data results the same way we did and draw the same conclusions. But it did not. We have no problem admitting we were shocked and stunned at the result -- we still are.
Hot Healthcare Technology Companies To Buy Right Now: Honda Motor Company Ltd. (HMC)
Honda Motor Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and distribution of motorcycles, automobiles, and power products primarily in North America, Europe, and Asia. Its motorcycle line consists of business and commuter models, as well as sports models, including trial and moto-cross racing; all?terrain vehicles; personal watercrafts; and multi utility vehicles. The company also produces various automobile products, including passenger cars, minivans, multi-wagons, sport utility vehicles, and mini cars; and power products comprising tillers, portable generators, general-purpose engines, grass cutters, outboard marine engines, water pumps, snow throwers, power carriers, power sprayers, lawn mowers and lawn tractors, home-use cogeneration units, and thin film solar cells for home, public, and industrial uses. In addition, it sells spare parts and provides after sales services are through retail dealers, as well as offers retail lendin g and leasing to customers, and wholesale financing to dealers. The company was founded in 1946 and is based in Tokyo, Japan.
Advisors' Opinion:- [By GURUFOCUS]
Edmund estimates that 1.14 million vehicles will be sold in the month of September, which is 24% down from August sales of 1.5 million cars and trucks. Korean based auto manufacturer Hyundai Motor is expected to experience sales decline of 15%. Japanese auto players are also estimated to witness sales drop. Of them, Nissan (NSANY) is expected to see steep sales drop of 8.9%, Honda Motors (HMC) should report a decline of approximately 5% for the month, while global lead automaker Toyota (T) is forecast to record 1.6% drop.
- [By Ben Levisohn]
No one expected the legacy automakers to remain on the sidelines and let Tesla Motors (TSLA) dominate electric autos. And today, there’s word on the competition as Honda Motor (HMC) and Toyota Motor (TM) both updated plans for their fuel-cell-powered vehicles.
- [By Live Investor]
The carmaker intends to invest heavily in its China operations to expand and make the maximum benefit from this growing potential market. China, which has a car market estimated to clock almost 32 million units by 2020, is increasingly becoming the hot spot and a dream destination for carmakers. It would be quite a challenge for the auto major given the strong presence of fellow foes GM, Volkswagen (VLKAY), Toyota (TM), Honda (HMC) and other foreign players.
- [By Daniel Miller]
By the numbers
I bet you'd be surprised to hear that in 2012 General Motor's (NYSE: GM ) and Ford's vehicle recalls combined were less than Toyota's (NYSE: TM ) or Honda's (NYSE: HMC ) . Toyota took the top spot with 5.3 million vehicles recalled last year, which was nearly 2 million more than its Japanese rival Honda at 3.4 million. Ford and GM came in with significantly fewer recalls at 1.4 and 1.5 million, respectively. That's not an unusual result either; take a look at the graph below for cumulative recalls over the last three years:
Hot Healthcare Technology Companies To Buy Right Now: Keryx Biopharmaceuticals Inc.(KERX)
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment cancer and renal disease. The company?s products under development include KRX-0401 (perifosine), an oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, as well as affects other pathways associated with programmed cell death, cell growth, cell differentiation, and cell survival. Its KRX-0401 is in Phase III clinical development stage for the treatment of refractory advanced colorectal cancer and multiple myeloma, as well as in Phase I and Phase II clinical development stages for the treatment of other tumor types. The company is also developing Zerenex (ferric citrate), an oral, ferric iron-based compound that is in Phase III clinical development for the treatment of hyperphosphatemia in patients with end-stage renal disease o n dialysis. Keryx Biopharmaceuticals, Inc. has commercial license agreements with Zentaris AG for the development of KRX-0401; Panion & BF Biotech, Inc. for the development and marketing of Zerenex; and Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Zerenex in Japan. The company was founded in 1997 and is based in New York, New York.
Advisors' Opinion:- [By gurujx]
Keryx Biopharmaceuticals Inc. (KERX): CFO James F. Oliviero III Sold 109,500 Shares
CFO�James F. Oliviero III�sold 109,500 shares of KERX stock on 12/30/2013 at the average price of $12.64. James F. Oliviero III owns at least 476,429 shares after this. The price of the stock has decreased by 3.32% since.
- [By MONEYMORNING]
Case in point: Keryx Biopharmaceuticals (Nasdaq: KERX) is a small biotech (market cap: $1.29B) with an experimental drug, Zerenex, that treats elevated phosphate levels and iron deficiency anemia in patients on dialysis for advanced chronic kidney disease (CKD).
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent. - [By Keith Speights and Max Macaluso, Ph.D.]
Health care analyst Max Macaluso recently sat down with Fool contributor Keith Speights to talk about some of the best speculative biotech plays on the market. Max and Keith discussed three companies that investors should consider: Keryx Pharmaceuticals (NASDAQ: KERX ) , Sarepta Therapeutics (NASDAQ: SRPT ) , and MannKind (NASDAQ: MNKD ) .
Hot Healthcare Technology Companies To Buy Right Now: Spectrum Rare Earths Ltd (SPX)
Spectrum Rare Earths Limited, formerly TUC Resources Ltd, is engaged in the exploration and evaluation of rare earths, uranium, base metals and gold mineral interests. On October 2, 2012, holds approximately 18,000 square kilometer of prospective land package across 44 tenements. During the fiscal year ended June 30, 2011, the Company is focuses on its Stromberg Heavy Rare Earth Project. The Company has 50, 100% owned tenements in the Northern Territory. Tenements within the Pine Creek Project consist of EL's 24884, 25224, 25228 and uranium rights on EL24906. Parts of EL24906 and EL24884 are located within the Rum Jungle Mineral Field. The Arnhem Project encompasses all the Company�� tenement holdings in the East Alligator River region within 150 kilometer of the high grade Narbalek uranium mine. The Litchfield Uranium Project consists of granted licenses EL25195 and EL25176 and license applications 25472, 25473 and 25221. Advisors' Opinion:- [By Alex Barinka]
Economic growth amid monetary stimulus from the Federal Reserve has helped send the S&P 500 (SPX) up 141 percent from its bear-market low in 2009, including a 14 percent rally so far this year. The index has slipped 2.2 percent from its last record on May 21 after Fed Chairman Ben S. Bernanke said the central bank could begin to reduce bond purchases should the employment market show sustainable growth.
Hot Healthcare Technology Companies To Buy Right Now: Amsurg Corp.(AMSG)
AmSurg Corp., through its wholly owned subsidiaries, engages in the development, acquisition, and operation of ambulatory surgery centers in partnership with physicians in the United States. The company?s surgery centers perform colonoscopy and other endoscopy procedures in the area of gastroenterology; cataracts and retinal laser surgery in the area of ophthalmology; and knee and shoulder arthroscopy and carpal tunnel repair in the area of orthopedics. As of December 31, 2010, it owned interest in 204 surgery centers in 33 states and the District of Columbia, including 140 centers performed gastrointestinal endoscopy procedures, 37 centers performed ophthalmology surgery procedures, 19 centers were multiple specialties, and 8 centers performed orthopaedic procedures. AmSurg Corp. markets its surgery centers directly to patients; and referring physicians and third-party payors, such as health maintenance organizations, preferred provider organizations, other managed care o rganizations, and employers. The company was founded in 1992 and is headquartered in Nashville, Tennessee.
Advisors' Opinion:- [By Tom Lydon]
Top holdings based on the index include Acadia Healthcare Companies (ACHC), Amsurg Corporation (AMSG), Brookdale Senior Living (BKD), Clarcor (CLC) and Community Health Systems (CYH).
- [By John Reese]
Indeed, in 2013, the Greenblatt-based portfolio has bounced back strong, returning more than 50%. Below is a look at its current holdings.
EBIX, Inc. (EBIX)
Western Refining (WNR)
DirecTV (DTV)
ITT Educational Services (ESI)
Science Applications International (SAIC)
Weight Watchers International (WTW)
ConocoPhillips (COP)
AmSurg Corp. (AMSG)
PDL BioPharma (PDLI)
AFC Enterprises (AFCE)
Subscribe to Validea here��/p>
- [By Garrett Cook]
Shares of AmSurg (NASDAQ: AMSG) were 2.07 percent to $44.85 after the company priced 8.5 million share offering at $45.00 per share. Baird upgraded Amsurg from Neutral to Outperform and raised the price target from $44.00 to $55.00.
No comments:
Post a Comment